Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer
1 competing product in clinical development for Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| mRNA-2416 | Moderna | Phase 2 | Terminated | 0 |